Optimal Intervention to Full Viral Suppression: Text Me, Alexis!
Comparative- and Cost-effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women Living With HIV to Full Viral Suppression
Sponsor: Friends Research Institute, Inc.
Terminated
President Trump's Executive Order
Other terminated trials from Friends Research Institute, Inc.
More terminations from Friends Research Institute, Inc.
Listed as NCT06408350, this NA trial focuses on HIV and remains terminated or withdrawn. Sponsored by Friends Research Institute, Inc., it has been updated 6 times since 2024, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
6 versions recorded-
Feb 2026 — Present [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Aug 2025 — Feb 2026 [monthly]
Recruiting NA
Status: Terminated → Recruiting
-
May 2025 — Aug 2025 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2024 — May 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
First recorded
Apr 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Friends Research Institute, Inc.
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .